Context:
- Oura is involved in numerous patent disputes in the United States and India over wearable fitness-tracking technology.
- Late last year it sued Zepp Health in the U.S. District Court for the Eastern District of Texas (November 18, 2025 ip fray article); Zepp responded with a countersuit in the same court (April 22, 2026 ip fray article).
- Oura also filed a complaint at the U.S. International Trade Commission (ITC) seeking import bans for Zepp and other competitors, including Samsung – which is also engaged in district court litigation with Oura (December 2, 2025 ip fray article).
- At the U.S. Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB), Samsung has filed multiple petitions for inter partes review (IPR) and post-grant review (PGR) of various Oura patents since 2024 (December 1, 2025 ip fray article).
To Read The Full Story
Continue reading your article with a Membership
Counsel
PTAB panel: Administrative Patent Judges Linda E. Horner, Neil T. Powell, and Michael A. Valek.
Samsung is represented by O’Melveny & Myers’ William M. Fink, John Kappos, Benjamin Haber, Marc Pensabene, Mark Liang, Sorin G. Zaharia, and Brooke M. Wilner.
Oura is represented by Mayer Brown’s Jasjit S. Vidwan, Robert G. Pluta, James A. Fussell III, Saqib J. Siddiqui, Bryan C. Nese, Michael L. Lindinger, Tiffany A. Miller, Alison T. Gelsleichter, Amanda E. Stephenson, Seth W. Bruneel, Courtney Krawice, Paul Choi, So Ra Ko, Nicholas H. Ciulla, Angeline Premraj, and Dongwook Kim; and Patton Tidwell & Culbertson’s Geoff Culbertson and Kelly Tidwell.
Zepp is represented by Jones Day’s David M. Maiorana and Keith B. Davis.